935670-07-8 Usage
General Description
1-AZETIDIN-3-YL-DIMETHYLAMINE HYDROCHLORIDE is a chemical compound that is used in the pharmaceutical industry as an intermediate in the synthesis of various drugs. It is a hydrochloride salt of 1-azetidin-3-yl-dimethylamine, which is a five-membered heterocyclic compound containing a nitrogen atom. 1-AZETIDIN-3-YL-DIMETHYLAMINE HYDROCHLORIDE is a tertiary amine, meaning it has three alkyl groups attached to the nitrogen atom. It is commonly used as a building block for the synthesis of various pharmaceuticals, including antiviral drugs and antihistamines. Additionally, it is used as a reagent in organic chemistry reactions. As a hydrochloride salt, it is a stable and easily handled form of the compound, making it convenient for use in pharmaceutical manufacturing processes.
Check Digit Verification of cas no
The CAS Registry Mumber 935670-07-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,3,5,6,7 and 0 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 935670-07:
(8*9)+(7*3)+(6*5)+(5*6)+(4*7)+(3*0)+(2*0)+(1*7)=188
188 % 10 = 8
So 935670-07-8 is a valid CAS Registry Number.
935670-07-8Relevant articles and documents
2 - (2, 4, 5 - SUBSTITUTED -ANILINO) PYRIMIDINE DERIVATIVES AS EGFR MODULATORS USEFUL FOR TREATING CANCER
-
, (2013/03/26)
The present invention relates to certain 2-(2,4,5-substituted-anilino) pyrimidine compounds and pharmaceutically acceptable salts thereof which may be useful in the treatment or prevention of a disease or medical condition mediated through certain mutated forms of epidermal growth factor receptor (for example the L858R activating mutant, the Exonl9 deletion activating mutant and the T790M resistance mutant). Such compounds and salts thereof may be useful in the treatment or prevention of a number of different cancers. The invention also relates to pharmaceutical compositions comprising said compounds and salts thereof, especially useful polymorphic forms of these compounds and salts, intermediates useful in the manufacture of said compounds and to methods of treatment of diseases mediated by various different forms of EGFR using said compounds and salts thereof.
